The content is available as a PDF (186.1 KB).
. 2022 Apr 25;24(5):S109–S110. doi: 10.1016/S1465-3249(22)00303-6
Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY: A NEW POSSIBILITY FOR COVID- 19 TREATMENT
N Kim
, J Lee
, E Oh
, D Jekarl
, D Lee
, K Im
, S Cho
N Kim
Find articles by N Kim
J Lee
Find articles by J Lee
E Oh
Find articles by E Oh
D Jekarl
Find articles by D Jekarl
D Lee
Find articles by D Lee
K Im
Find articles by K Im
S Cho
Find articles by S Cho
Issue date 2022 May.
Copyright © 2022 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9035761